907 resultados para Pharmaceutical-industry


Relevância:

60.00% 60.00%

Publicador:

Resumo:

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Through observation of the production process industries today, one can encounter the needs of the large uncertainties related improvements and changes in the production environment, a fact that inspired the search for solutions that can respond quickly to these changes. Thus, this paper describes the review of implementation of TPM (total productivity management), which aims to optimize two distinct processes in the Vale do Paraíba´s pharmaceutical industry one of through the pillar of specific improvement. The main objective is to propose an efficient alternative to proposing loss management processes by identifying and eliminating the same in a systematic process. To develop this analysis was necessary to explore concepts of TPM and tools that help in taking data, identification and clarification of the phenomena that cause failures in the process, which were essential to ensure the development of the analysis. The concepts covered are usually presented during an undergraduate degree in Engineering. Data compiled by the analysis are able to serve as a strategic benchmark for decision making by managers, providing alternative response variables and uncertainty of the organizational environment, a fact that facilitates the management of human resources and productive

Relevância:

60.00% 60.00%

Publicador:

Resumo:

The objective of this study is to examine the pharmaceutical industry and changes that the fall of patents and entry of generics may cause in the price and consumption of drugs. Thus, there is a brief discussion about the global pharmaceutical industry, from its origins to the present day, showing in particular the case of the United States, today considered the largest industry in this sector. From this, the work seeks to address specifically the Brazilian industry and its regulation. Since the generic law implementation, the participation of this type of medicine has grown significantly in the country. Because they have always been lower than prices of their brand, the cost of treating disease is reduced, which makes generic drugs represent an improvement for consumers in terms of welfare of society

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999

Relevância:

60.00% 60.00%

Publicador:

Resumo:

This work aims to evaluate the different trajectories in terms of production structure, technological capabilities and performance in international trade of pharmaceutical industries in Brazil and India. For this, we build international trade indicators, based on data provided by the COMTRADE, the UN database for trade. Through the indicators, it is observed that the countries have different results in the catch-up process of the pharmaceutical industry. India has built a productive structure strongly based on generic drugs, with which it is able to greatly meet domestic demand and export to many countries worldwide. Brazil remains in a position of dependence of foreign production, with a high level of imports and exports to the region of Latin America

Relevância:

60.00% 60.00%

Publicador:

Resumo:

The article shows how the development of the pharmaceutical industry in Brazil and India occurred, and why the industry in these two countries, which until the 1970s were much alike, today show significant differences. The historical analysis of the trajectories of the industries in both countries showed that the Indian industry has a higher technological content, due to, among others, the efficiency of public policies implemented since the 1970s, which were aimed at improving not only production, but also the technological development.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Pós-graduação em Ciências da Motricidade - IBRC

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Fusidic acid, an antibiotic produced from the Fusidium coccineum fungus, belongs to the class of steroids, but has no corticosteroid effects. It is indicated for the treatment of infections caused by methicillin-resistant Staphylococcus aureus strains. The aim of this study was to search for the properties of fusidic acid published so far in the literature, as well as the methods developed for its determination in biological samples and pharmaceutical formulations. From the findings, we can conclude that fusidic acid has been used for decades and is indicated for the treatment of serious infections caused by Gram-positive microorganisms to this day. Furthermore, it is a hypoallergenic agent, has low toxicity, shows low resistance, and has no cross-resistance with other clinically used antibiotics. The analytical method of high-performance liquid chromatography has been widely used, since it can reduce the cost and time of analysis, making it more viable for routine quality control in the pharmaceutical industry.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Pós-graduação em Agronomia (Horticultura) - FCA